Your browser doesn't support javascript.
loading
Development of a novel PTD-mediated IVT-mRNA delivery platform for potential protein replacement therapy of metabolic/genetic disorders.
Miliotou, Androulla N; Pappas, Ioannis S; Spyroulias, George; Vlachaki, Efthimia; Tsiftsoglou, Asterios S; Vizirianakis, Ioannis S; Papadopoulou, Lefkothea C.
Afiliação
  • Miliotou AN; Laboratory of Pharmacology, School of Pharmacy, Faculty of Health Sciences, Aristotle University of Thessaloniki, Thessaloniki, 546 42 Macedonia, Greece.
  • Pappas IS; Laboratory of Pharmacology and Toxicology, Faculty of Veterinary Science, University of Thessaly, Karditsa, 431 00 Thessaly, Greece.
  • Spyroulias G; Department of Pharmacy, University of Patras, 265 04 Patras, Greece.
  • Vlachaki E; Adult Thalassemia Unit, Hippokrateion General Hospital, Thessaloniki, 546 42 Macedonia, Greece.
  • Tsiftsoglou AS; Laboratory of Pharmacology, School of Pharmacy, Faculty of Health Sciences, Aristotle University of Thessaloniki, Thessaloniki, 546 42 Macedonia, Greece.
  • Vizirianakis IS; Laboratory of Pharmacology, School of Pharmacy, Faculty of Health Sciences, Aristotle University of Thessaloniki, Thessaloniki, 546 42 Macedonia, Greece.
  • Papadopoulou LC; Department of Life and Health Sciences, University of Nicosia, 1700 Nicosia, Cyprus.
Mol Ther Nucleic Acids ; 26: 694-710, 2021 Dec 03.
Article em En | MEDLINE | ID: mdl-34703653
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Mol Ther Nucleic Acids Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Grécia
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Mol Ther Nucleic Acids Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Grécia